10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Diagnoses and Outcomes of Patients with Suspicion of Acute Coronary Syndrome and Raised High Sensitive Troponin I: A Single Center Study from Pakistan

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives  Troponins are classically raised in acute coronary syndrome (ACS) although other cardiovascular and non-cardiovascular causes are recognized. We aimed to see the association of high sensitivity (Hs) Troponin I values exceeding the sex-specific 99th percentile upper reference limit (URL) with diagnoses, emergency department (ED) outcomes, 30-day outcomes of admitted patients and predictors of ACS in both genders.

          Materials and Methods  A retrospective study of all patients presenting to the emergency department from January 2019 to April 2021 with suspicion of ACS and Hs-Troponin I values greater than the sex-specific 99th percentile URL.

          Statistical Analysis  SPSS version 24 was used, Pearson's chi-square tests, Fisher's exact test, Kruskal–Wallis test, Mann–Whitney U test, and odds ratios, including the 95% confidence intervals, for each characteristic were used for analysis. A p -value of < 0.05 was considered significant.

          Results  There were a total of 5,982 patients (3,031 males, 2,951 females), out of which 878 patients were admitted under the cardiology specialty. In patients who were admitted to the ward, mortality was higher in females (8.2%) with less than a 10-fold rise in Hs-Troponin I while similar in both genders (7.6%) in patients with Hs-troponin I greater than 10-fold of sex-specific 99th percentile URL. Raised low-density lipoprotein-cholesterol was a significant factor associated with 2.4 times higher odds of ACS.

          Conclusion  Women with Hs-Troponin values up to 10 times the URL, i.e., 15.6–160 ng/L have higher mortality than their male counterparts. LDL-cholesterol is a significant risk factor for ACS which should be controlled for its prevention.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: not found
          • Article: not found

          Fourth universal definition of myocardial infarction (2018)

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study.

            To evaluate the diagnosis of myocardial infarction using a high sensitivity troponin I assay and sex specific diagnostic thresholds in men and women with suspected acute coronary syndrome.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome

              Question What is the optimal high-sensitivity cardiac troponin I concentration at presentation to risk-stratify patients with suspected acute coronary syndrome? Findings In an individual patient-level meta-analysis of 22 457 patients from 9 countries, troponin I concentrations were less than 5 ng/L in 49%, among whom 5 per 1000 patients had a myocardial infarction or cardiac death at 30 days. Meaning Among patients with suspected acute coronary syndrome, a high-sensitivity cardiac troponin I threshold of less than 5 ng/L identified patients at low risk of cardiac events; further research is needed to assess the clinical utility of this test. Importance High-sensitivity cardiac troponin I testing is widely used to evaluate patients with suspected acute coronary syndrome. A cardiac troponin concentration of less than 5 ng/L identifies patients at presentation as low risk, but the optimal threshold is uncertain. Objective To evaluate the performance of a cardiac troponin I threshold of 5 ng/L at presentation as a risk stratification tool in patients with suspected acute coronary syndrome. Data Sources Systematic search of MEDLINE, EMBASE, Cochrane, and Web of Science databases from January 1, 2006, to March 18, 2017. Study Selection Prospective studies measuring high-sensitivity cardiac troponin I concentrations in patients with suspected acute coronary syndrome in which the diagnosis was adjudicated according to the universal definition of myocardial infarction. Data Extraction and Synthesis The systematic review identified 19 cohorts. Individual patient-level data were obtained from the corresponding authors of 17 cohorts, with aggregate data from 2 cohorts. Meta-estimates for primary and secondary outcomes were derived using a binomial-normal random-effects model. Main Outcomes and Measures The primary outcome was myocardial infarction or cardiac death at 30 days. Performance was evaluated in subgroups and across a range of troponin concentrations (2-16 ng/L) using individual patient data. Results Of 11 845 articles identified, 104 underwent full-text review, and 19 cohorts from 9 countries were included. Among 22 457 patients included in the meta-analysis (mean age, 62 [SD, 15.5] years; n = 9329 women [41.5%]), the primary outcome occurred in 2786 (12.4%). Cardiac troponin I concentrations were less than 5 ng/L at presentation in 11 012 patients (49%), in whom there were 60 missed index or 30-day events (59 index myocardial infarctions, 1 myocardial infarction at 30 days, and no cardiac deaths at 30 days). This resulted in a negative predictive value of 99.5% (95% CI, 99.3%-99.6%) for the primary outcome. There were no cardiac deaths at 30 days and 7 (0.1%) at 1 year, with a negative predictive value of 99.9% (95% CI, 99.7%-99.9%) for cardiac death. Conclusions and Relevance Among patients with suspected acute coronary syndrome, a high-sensitivity cardiac troponin I concentration of less than 5 ng/L identified those at low risk of myocardial infarction or cardiac death within 30 days. Further research is needed to understand the clinical utility and cost-effectiveness of this approach to risk stratification. This systematic review evaluates the performance of a cardiac troponin I threshold of 5 ng/L at presentation as a risk stratification tool in patients with suspected acute coronary syndrome.
                Bookmark

                Author and article information

                Journal
                J Lab Physicians
                J Lab Physicians
                10.1055/s-00044881
                Journal of Laboratory Physicians
                Thieme Medical and Scientific Publishers Pvt. Ltd. (A-12, 2nd Floor, Sector 2, Noida-201301 UP, India )
                0974-2727
                0974-7826
                04 April 2023
                September 2023
                1 April 2023
                : 15
                : 3
                : 409-418
                Affiliations
                [1 ]Section of Chemical Pathology, Indus Hospital & Health Network, Karachi, Pakistan
                [2 ]Indus Hospital Research Centre, Indus Hospital & Health Network, Karachi, Pakistan
                [3 ]Department of Cardiology, Indus Hospital & Health Network, Karachi, Pakistan
                Author notes
                Address for correspondence Fatima Kanani, MBBS, FCPS Section Head and Consultant Chemical Pathologist, Indus Hospital & Health Network Plot C-76, Sector 31/5, Opposite Darussalam Society Korangi Crossing, Karachi 75190Pakistan fatimakanani@ 123456hotmail.com
                Author information
                http://orcid.org/0000-0001-6486-8886
                http://orcid.org/0000-0002-2214-9047
                http://orcid.org/0000-0001-5283-323X
                Article
                JLP-22-8-1383
                10.1055/s-0043-1761940
                10411135
                1e51a2e6-e5b7-4c42-bbdc-4027380cde27
                The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ )

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.

                History
                Funding
                Funding None.
                Categories
                Original Article

                Clinical chemistry
                acute coronary syndrome,myocardial infarction,non-st-elevation myocardial infarction (nstemi),cardiac troponin,ldl cholesterol,emergency department

                Comments

                Comment on this article